The DivGro Weekly—17.10.25
198 Consecutive dividend increases
Weekly Dividend Progress
This week we received further real-time, tangible evidence of outstanding business progress when we collected our quarterly dividend from Constellation Software. We also became entitled to our quarterly dividends from American Express, Abbott and Watsco, all meaningfully higher than this time last year.
How We Are Tracking
Since DivGro's inception we have predicted and benefited from 198 consecutive dividend increases across our portfolio companies, with no decreases. The average rate of these dividend increases is 14.4%.
Distribution
Next week, we will pay our 24th consecutive quarterly distribution. Notably, this distribution is 11.5% higher than the same time last year. DivGro has grown its distributions each year by at least a double-digit percentage increase. Our quarterly distribution is already 2.7x higher than our first quarterly distribution paid in January 2020.
Abbott
How does a 135-year-old healthcare giant maintain leadership in an ever-changing industry? By constantly anticipating and innovating for evolving health needs. For example? In the last five years, Abbott Laboratories has invested more than $15 billion in its R&D engine. This has given rise to products that uniquely address the concomitant muscle loss generated by GLP-1 medications, as well as more affordable biosimilars in order to provide treatment for cancer side effects in emerging markets. Simultaneously, the company’s acquisitions, including St Jude Medical, have enabled Abbott to penetrate and establish leadership in faster-growing markets such as heart valves. It is this holistic approach that drives the company towards its ambitious goal of improving the healthcare of one in three people by 2030 — and which has powered 53 years of consecutive dividend increases and a commensurate uplift in share price. By continually leveraging its exceptional reputation and trust, nurtured over more than a century, while working at the cutting edge, Abbott is poised to continue building upon its formidable record of dividend outperformance.